Advances in mechanisms for inflammation-associated colon carcinogenesis and chemoprevention
10.16438/j.0513-4870.2021-1452
- VernacularTitle:结肠炎癌转化调控机制和化学干预的研究进展
- Author:
Yi-tong LIU
;
Yang SUN
- Publication Type:Research Article
- Keywords:
inflammatory bowel disease;
colorectal cancer;
inflammatory signaling pathway;
inflammatory carcinomatosis;
chemoprevention
- From:
Acta Pharmaceutica Sinica
2022;57(5):1273-1281
- CountryChina
- Language:Chinese
-
Abstract:
Colorectal cancer is a common malignant tumor of digestive tract, and the risk of inflammatory bowel disease developing into colorectal cancer is significantly increased. Immune signaling pathways NF-κB, IL-6/STAT3, COX-2/PGE2, IL-23/Th17 and TLRs have been confirmed to promote the transformation from colitis to colorectal cancer. NOD2 and intestinal microbes also participate in the regulation of inflammation mediated carcinogenesis. Chronic inflammation is a potential risk for colorectal cancer, and anti-inflammatory drugs may play a chemical preventive role. In this review, we summarize the signaling pathways involved in inflammation-associated colon carcinogenesis and evaluate the chemoprophylaxis of colon cancer.
